- Home
- ZYME vs NGVC Comparison
ZYME vs NGVC Comparison
Compare ZYME & NGVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- NGVC
- Stock Information
- Founded
- ZYME 2003
- NGVC 1955
- Country
- ZYME United States
- NGVC United States
- Employees
- ZYME N/A
- NGVC N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- NGVC Food Chains
- Sector
- ZYME Health Care
- NGVC Consumer Staples
- Exchange
- ZYME Nasdaq
- NGVC Nasdaq
- Market Cap
- ZYME 867.6M
- NGVC 1.0B
- IPO Year
- ZYME 2017
- NGVC 2012
- Fundamental
- Price
- ZYME $13.30
- NGVC $40.20
- Analyst Decision
- ZYME Buy
- NGVC
- Analyst Count
- ZYME 7
- NGVC 0
- Target Price
- ZYME $19.50
- NGVC N/A
- AVG Volume (30 Days)
- ZYME 494.5K
- NGVC 318.5K
- Earning Date
- ZYME 07-31-2025
- NGVC 08-07-2025
- Dividend Yield
- ZYME N/A
- NGVC 1.21%
- EPS Growth
- ZYME N/A
- NGVC 42.37
- EPS
- ZYME N/A
- NGVC 1.78
- Revenue
- ZYME $93,384,000.00
- NGVC $1,297,733,000.00
- Revenue This Year
- ZYME $44.71
- NGVC $1.32
- Revenue Next Year
- ZYME $34.57
- NGVC N/A
- P/E Ratio
- ZYME N/A
- NGVC $21.96
- Revenue Growth
- ZYME 85.05
- NGVC 9.36
- 52 Week Low
- ZYME $9.03
- NGVC $22.14
- 52 Week High
- ZYME $17.70
- NGVC $61.22
- Technical
- Relative Strength Index (RSI)
- ZYME 61.39
- NGVC 45.75
- Support Level
- ZYME $12.75
- NGVC $37.57
- Resistance Level
- ZYME $13.80
- NGVC $40.22
- Average True Range (ATR)
- ZYME 0.42
- NGVC 1.99
- MACD
- ZYME 0.07
- NGVC 0.29
- Stochastic Oscillator
- ZYME 79.88
- NGVC 50.17
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About NGVC Natural Grocers by Vitamin Cottage Inc.
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.